Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody-induced glomerulonephritis in mice

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 2, 2010, Pages

  Lu, Hua ^a   Zhen, Junhui ^a,b   Wu, Tianfu ^c   Peng, Ai ^a,d   Ye, Ting ^a   Wang, Tao ^a   Yu, Xueqing ^e   Vaziri, Nosratola D ^f   Mohan, Chandra ^c   Zhou, Xin J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d TONGJI UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY   (China)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Catalase; Crescentic glomerulonephritis; Hydrogen peroxide; NF B; Oxidative stress

Indexed keywords

CATALASE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; OSTEOPONTIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; ENZYME ACTIVITY; GLOMERULONEPHRITIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY INJURY; LYMPHOCYTE; MACROPHAGE; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RABBIT; UPREGULATION;

EID: 77955365664     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00583.2009     Document Type: Article

References (41)

1. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37: 781-786, 2001. (Pubitemid 32199066)
2. Borza DB, Neilson EG, Hudson BG. Pathogenesis of Goodpasture syndrome: a molecular perspective. Semin Nephrol 23: 522-531, 2003.
3. Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 58: 658-673, 2000.
4. Cuzzocrea S, McDonald MC, Mazzon E, Filipe HM, Costantino G, Caputi AP, Thiemermann C. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of splanchnic artery occlusion and reperfusion. Shock 14: 150-156, 2000.
5. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Caputi AP, Thiemermann C. Tempol reduces the activation of nuclear factor-kappaB in acute inflammation. Free Radic Res 38: 813-819, 2004. (Pubitemid 39077368)
6. Duann P, Datta PK, Pan C, Blumberg JB, Sharma M, Lianos EA. Superoxide dismutase mimetic preserves the. glomerular capillary permeability barrier to protein. J Pharmacol Exp Ther 316: 1249-1254, 2006.
7. 2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 292: H649-H656, 2007.
8. Gao YJ, Lee RM. Hydrogen peroxide is an endothelium-dependent contracting factor in rat renal artery. Br J Pharmacol 146: 1061-1068, 2005. (Pubitemid 41785318)
9. Guron GS, Grimberg ES, Basu S, Herlitz H. Acute effects of the superoxide dismutase mimetic tempol on split kidney function in two-kidney one-clip hypertensive rats. J Hypertens 24: 387-394, 2006.
10. Hudkins KL, Giachelli CM, Eitner F, Couser WG, Johnson RJ, Alpers CE. Osteopontin expression in human crescentic glomerulonephritis. Kidney Int 57: 105-116, 2000.
11. Johnson RJ, Couser WG, Chi EY, Adler S, Klebanoff SJ. New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxidehalide system. J Clin Invest 79: 1379-1387, 1987.
12. Kakita N, Sasaguri Y, Kato S, Morimatsu M. Induction of gelatinolytic neutral proteinase secretion by lipid peroxide in cultured mesangial cells. Nephron 63: 94-99, 1993. (Pubitemid 23008164)
13. Kalluri R, Wilson CB, Weberl M, Gunwar S, Chonko AM, Neilson EG, Hudson BG. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Good-pasture syndrome. J Am Soc Nephrol 6: 1178-1185, 1995.
14. Kashihara N, Watanabe Y, Makino H, Wallner EI, Kanwar YS. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc Natl Acad Sci USA 89: 6309-6313, 1992.
15. Lan HY, Yu XQ, Yang N, Nikolic-Paterson DJ, Mu W, Pichler R, Johnson RJ, Atkins RC. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int 53: 136-145, 1998. (Pubitemid 28066913)
16. Little MA, Pusey CD. Rapidly progressive glomerulonephritis: current and evolving treatment strategies. J Nephrol 17, Suppl 8: S10-S19, 2004.
17. Makino A, Skelton MM, Zou A, Cowley AW Jr. Increased renal medullary H2O2 leads to hypertension. Hypertension 42: 25-30, 2003.
18. Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, Fukunaga M, Tamaki A, Kiyomoto H, Kohno M, Shokoji T, Kimura S, Abe Y. The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt sensitive rats. J Am Soc Nephrol 15: 306-315, 2004.
19. Quiroz Y, Ferrebuz A, Vaziri ND, Rodriguez-Iturbe B. Effect of chronic antioxidant therapy with superoxide dismutase-mimetic drug, tempol, on progression of renal disease in rats with renal mass reduction. Nephron Exp Nephrol 112: e31-e42, 2009.
20. Rehan A, Johnson KJ, Wiggins RC, Kunkel RG, Ward PA. Evidence for the role of oxygen radicals in acute nephrotoxic nephritis. Lab Invest 51: 396-403, 1984. (Pubitemid 14021012)
21. Rogers TE, Rakheja D, Zhou XJ. Glomerular disease associated with nephritic syndrome and/or rapidly progressive glomerulonephritis. In: Silva's Diagnostic Renal Pathology. edited by Zhou XJ, Laszik Z, Nadasdy T, D'Agati V, and Silva FG. New York: Cambridge University Press, 2009, p. 178-228.
22. Roveri A, Coassin M, Maiorino M, Zamburlini A, van Amsterdam FT, Ratti E, Ursini F. Effect of hydrogen peroxide on calcium homeostasis in smooth muscle cells. Arch Biochem Biophys 297: 265-270, 1992. (Pubitemid 23282879)
23. Sainz J, Wangensteen R, Rodríguez Gómez. I, Moreno JM, Chamorro V, Osuna A, Bueno P, Vargas F. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Am J Hypertens 18: 871-877, 2005.
24. Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 33: 424-428, 1999.
25. Shah SV, Baliga R, Rajapurkar M, Fonseca VA. Oxidant in chronic kidney disease. J Am Soc Nephrol 18: 16-28, 2007.
26. Shah SV, Baricos WH, Basci A. Degradation of human glomerular basement membrane by stimulated neutrophils. Activation of a metalloproteinase(s) by reactive oxygen metabolites. J Clin Invest 79: 25-31, 1987.
27. Tatchum-Talom R, Martin DS. Tempol improves vascular function in the mesenteric vascular bed of senescent rats. Can J Physiol Pharmacol 82: 200-207, 2004.
28. Thakali K, Davenport L, Fink GD, Watts SW. Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and hypertensive rats. Hypertension 47: 482-487, 2006. (Pubitemid 43740294)
29. Thiemermann C. Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation. Crit Care Med 31: S76-S84, 2003.
30. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84, 2007.
31. Vaziri ND, Dicus M, Ho ND, Boroujerdi-Rad L, Sindhu RK. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int 63: 179-185, 2003.
32. Vaziri ND, Ding Y, Ni Z. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther 298: 679-685, 2001. (Pubitemid 32673420)
33. Vissers MC, Winterbourn CC. The effect of oxidants on neutrophil-mediated degradation of glomerular basement membrane collagen. Biochim Biophys Acta 889: 277-286, 1986.
34. Weiss SJ, Young J, LoBuglio AF, Slivka A, Nimeh N. Role of hydrogen peroxide in neutrophil mediated destruction of cultured endothelial cells. J Clin Invest 68: 714-721, 1981.
35. Williams JM, Pollock JS, Pollock DM. Arterial pressure response to the antioxidant tempol and ETB receptor blockade in rats on a high-salt diet. Hypertension 44: 770-775, 2004.
36. Wu T, Xie C, Bhaskarabhatla; M, Leone A, Chen SS, Zhou XJ, Putterman C, Mohan C. Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum 56: 949-959, 2007.
37. Xie C, Qin X, Jonnala G, Gong Y, Yan M, Zong P, Zhou XJ, Mohan C. Enhanced susceptibility to immune nephritis in DBA/1 mice is contingent upon IL-1 expression. Clin Immunol 124: 49-56, 2007. (Pubitemid 46951035)
38. Xie C, Sharma R, Wang H, Zhou XJ, Mohan C. .Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol 172: 5047-5055, 2004.
39. Yoshioka T, Ichikawa I, Fogo A. Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 2: 902-912, 1991.
40. Yu XQ, Fan JM, Nikolic-Paterson DJ, Yang N, Mu W, Pichler R, Johnson RJ, Atkins RC, Lan HY. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. Am J Pathol 154: 833-841, 1999.
41. Zhou XJ, Laszik Z, Wang XQ, Silva FG, Vaziri ND. Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest 80: 1905-1914, 2000.